From: Management of chronic spontaneous urticaria: a worldwide perspective
Treatment | Compared groups | n | % (n) of physicians, who follow the guidelines | % (n) of physicians, who don’t follow the guidelines | X2 | p |
---|---|---|---|---|---|---|
First-generation H1-antihistamines | Administer | 156 | 13.1 (136) | 22.7 (20) | 6.297 | 0.012 |
No | 970 | 86.9 (902) | 77.3 (68) | |||
Second-generation H1-antihistamines at standard dose | Administer | 127 | 11.3 (117) | 11.4 (10) | 0.001 | 0.979 |
No | 999 | 88.7 (921) | 88.6 (78) | |||
Updosed second-generation H1-antihistamines | Administer | 651 | 58.8 (610) | 46.6 (41) | 4.931 | 0.026 |
No | 475 | 41.2 (428) | 53.4 (47) | |||
H2-antihistamines (e.g. famotidine or ranitidine) | Administer | 308 | 27.1 (281) | 30.7 (27) | 0.532 | 0.466 |
No | 818 | 72.9 (757) | 69.3 (61) | |||
Ciclosporin | Administer | 76 | 6.8 (71) | 5.7 (5) | 0.173 | 0.678 |
No | 1050 | 93.2 (967) | 94.3 (83) | |||
Omalizumab | Administer | 163 | 14.5 (150) | 14.8 (13) | 0.007 | 0.934 |
No | 963 | 85.5 (888) | 85.2 (75) | |||
Montelukast | Administer | 391 | 35.5 (368) | 26.1 (23) | 3.106 | 0.078 |
No | 735 | 64.5 (670) | 73.9 (65) | |||
Dapsone | Administer | 39 | 3.2 (33) | 6.8 (6) | 3.213 | 0.073 |
No | 1087 | 96.8 (1005) | 93.2 (82) | |||
Systemic corticosteroids (for less than 10 days) | Administer | 265 | 23.8 (247) | 20.5 (18) | 0.503 | 0.478 |
No | 861 | 76.2 (791) | 79.5 (70) | |||
Systemic corticosteroids (for more than 10 days in a row) | Administer | 89 | 7.4 (77) | 13.6 (12) | 4.309 | 0.038 |
No | 1037 | 92.6 (961) | 86.4 (76) | |||
Tricyclic antidepressants (e.g. doxepin) | Administer | 137 | 11.6 (120) | 19.3 (17) | 4.568 | 0.033 |
No | 989 | 88.4 (918) | 80.7 (71) |